Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neurofibromatosis 1 3Breast Neoplasms 3Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Noonan Syndrome 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Learning Disabilities 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Dyslexia 1Cognition Disorders 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 12Amifostine 7Cisplatin 6Etoposide 3Carboplatin 3Bevacizumab 3Radiotherapy, Intensity-Modulated 2Radiation 2Paclitaxel 2Heavy Ion Radiotherapy 2Fluorouracil 2sargramostim 1lithium sulfate 1Vincristine 1Surgical Procedures, Operative 1Steroids 1Selenomethionine 1Rituximab 1Protons 1Proton Therapy 1Procarbazine 1Physical Therapy Modalities 1Photons 1Palonosetron 1Olanzapine 1Methylprednisolone 1Methotrexate 1Mental Status and Dementia Tests 1Melatonin 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Radiation Injuries × Lovastatin × Clear all
NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡